https://www.selleckchem.com/pr....oducts/sgc-cbp30.htm
tage CKD may influence the timing of kidney transplantation. Since the change in erythropoiesis-stimulating agent (ESA) labeling and bundling of dialysis services in the United States, few studies have addressed the clinical importance of ESA hyporesponsiveness and none have considered health care resource use in this population. We aimed to further explore ESA hyporesponsiveness and its consequences. Retrospective observational cohort study. US Renal Data System Medicare participants receiving dialysis with a minimum 6 months of cont
Like
Comment
Share
